MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
APYX — Apyx Medical Corporation Common Stock
NasdaqApyx Medical Corporation Common Stock
$2.55
+0.05(+2.00%)
- O
- 2.51
- H
- 2.60
- L
- 2.50
- V
- 51.23K
⏱️ End-of-day dataAs of Oct 2, 2026
APYX — Latest News & Headlines
7 StoriesEvery participant in Apyx Medical's study reported improved skin elasticity, radiance and youthfulness - Stock Titan
Every participant in Apyx Medical's study reported improved skin elasticity, radiance and youthfulness Stock Titan
Apyx Medical: Negative Cash Flow And High Valuation (NASDAQ:APYX) - Seeking Alpha
Apyx Medical: Negative Cash Flow And High Valuation (NASDAQ:APYX) Seeking Alpha
Apyx Medical Reports Clinical Study Showing Renuvion May Improve Skin Quality Markers and Dermal Remodeling - Quiver Quantitative
Apyx Medical Reports Clinical Study Showing Renuvion May Improve Skin Quality Markers and Dermal Remodeling Quiver Quantitative
APYX Initiates Coverage On by Maxim Group -- Price Target Announ - GuruFocus
APYX Initiates Coverage On by Maxim Group -- Price Target Announ GuruFocus
Form 8K Apyx Medical Inc For: 29 September By Investing.com - Investing.com UK
Form 8K Apyx Medical Inc For: 29 September By Investing.com Investing.com UK
Apyx Medical reports study results on Renuvion skin treatment By Investing.com - Investing.com Canada
Apyx Medical reports study results on Renuvion skin treatment By Investing.com Investing.com Canada
Apyx Medical Highlights Renuvion Clinical Study Results - TipRanks
Apyx Medical Highlights Renuvion Clinical Study Results TipRanks